AW
VYGR icon

Avion Wealth’s Voyager Therapeutics VYGR Stock Holding History

Avion Wealth’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
169
– – ﹤0.01% 1771
2026
Q1 		$0 Hold
169
– – ﹤0.01% 1628
2025
Q4 		$0 Hold
169
– – ﹤0.01% 1616
2025
Q3 		$0 Buy
169
+9
+6% +$33 ﹤0.01% 1577
2025
Q2 		$0 Buy
+160
New +$516 ﹤0.01% 1642

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Avion Wealth's VYGR Position: Q2 2026 in Review

Avion Wealth held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 169 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

Avion Wealth first reported a position in VYGR in Q2 2025 and has held it in 5 quarters since. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Avion Wealth held 169 shares of Voyager Therapeutics worth $0 as of Q2 2026.
  • Avion Wealth left its Voyager Therapeutics share count unchanged in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1771 holding.
  • Avion Wealth first reported a position in Voyager Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.